“If you can look into the seeds of time, and say which grain will grow and which will not, speak then unto me.”

-William Shakespeare

PharmGPS® assesses the current relative performance of drugs in development and predicts the immediate future performance of these drugs with the power to transform healthcare

The new healthcare economy requires a drugs that will transform the standard of care in the particular therapeutic area. PharmGPS® provides predictive analytics that identify promising drugs with the highest Probability of Success and predict its future trajectory.

Welcome to The PharmGPS® Advantage!

Predict the future performance of a drug from early stage clinical data

Decision making at your fingertips

War gaming scenarios

Early identification of value and blind spots

Predicting market winners in early stages giving 10-18 months’ time advantage

Due diligence support through competitive landscape

NPV of major late stage pipeline assets

Comprehensive strategic intent maps enable streamline of internal analysis and external innovation.

Identify of short-term and long-term opportunities with potential market entry scenarios.

Monitor real-time drug development information

Therapeutic Area Landscape – encompassing 100+ diseases and 7000+ orphan diseases

Customized Clinical Assets Benchmarking

Determine status and progress of pertinent clinical trials

Map relevant disease pathways

Compare investigational and marketed drugs related to defined targets

Stay updated on market dynamics & differentiate your product in the market Dashboard view on the clinical phase progression

Forecast future and current market products

Identify potential business partners

Discover new markets for your assets

First mover advantage (search & evaluation to identify market winners)

Understand gaps in the current treatment paradigm

Identify your competitors | Increase R&D outcomes

Asset and portfolio differentiation/business case for evaluating assets

Predict future trends

Explore PharmGPS®